Shikonin combined with curcumin synergistically induces apoptosis of glioma cells by inhibiting the PI3K/Akt/NF‑κB signaling pathway
Oncology Letters · 23.10.2026 · 32 (6) · 1-12
DOI: 10.3892/ol.2026.15918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 23.10.2026. Verfasst von Xiaojin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xiaolan Clinical Institute of Shantou University Medical College, Zhongshan, Guangdong 528415, P.R. China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Xiaolan Clinical Institute of Shantou University Medical College, Zhongshan, Guangdong 528415, P.R. China.
- Department of Psychological Sleep, Xiaolan People's Hospital of Zhongshan 'The Fifth People's Hospital of Zhongshan', Zhongshan, Guangdong 528415, P.R. China.
- Department of Neurosurgery, Xiaolan People's Hospital of Zhongshan 'The Fifth People's Hospital of Zhongshan', Zhongshan, Guangdong 528415, P.R. China.
Zitieren
APA
Zhao, X., Zhang, M., He, Y., Yu, Z., Sun, Y., & Zhu, J. (2026). Shikonin combined with curcumin synergistically induces apoptosis of glioma cells by inhibiting the PI3K/Akt/NF‑κB signaling pathway. Oncology Letters, 32(6), 1-12. https://doi.org/10.3892/ol.2026.15918
Vancouver
Zhao X, Zhang M, He Y, Yu Z, Sun Y, Zhu J. Shikonin combined with curcumin synergistically induces apoptosis of glioma cells by inhibiting the PI3K/Akt/NF‑κB signaling pathway. Oncology Letters. 2026;32(6):1-12. doi:10.3892/ol.2026.15918
BibTeX
@article{Zhao2026,
author = {Zhao, Xiaojin and Zhang, Mingwen and He, Yongchao and Yu, Zhihu and Sun, Yichun and Zhu, Jiabin},
title = {Shikonin combined with curcumin synergistically induces apoptosis of glioma cells by inhibiting the PI3K/Akt/NF‑κB signaling pathway},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {6},
pages = {1--12},
doi = {10.3892/ol.2026.15918}
}
EUVIMED